Astellas Pharma Inc

Research Astellas Pharma Inc (YPH) with Bullrun company financials, valuation charts, model signals, and historical stock context.

Key Metrics

• TickerYPH
• ExchangeDU
• CurrencyEUR
• Financial periodFY2025
• RevenueEUR 1.91T
• Revenue growth19.2%
• Net incomeEUR 50.75B
• Free cash flowEUR 137.18B
• Gross margin81.7%